‌

US Patent 11859190 Methods and compositions for regulation of transgene expression

Patent 11859190 was granted and assigned to Sangamo Therapeutics on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Sangamo Therapeutics

0

Current Assignee

Sangamo Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Edward J. Rebar0

Date of Patent

January 2, 2024

0

Patent Application Number

171909940

Date Filed

March 3, 2021

0

Patent Citations

US Patent 7067317 Regulation of angiogenesis with zinc finger proteins

0

US Patent 7070934 Ligand-controlled regulation of endogenous gene expression

0

US Patent 7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers

0

US Patent 7163824 Regulation of endogenous gene expression in cells using zinc finger proteins

0

US Patent 7253273 Treatment of neuropathic pain with zinc finger proteins

0

US Patent 7262054 Zinc finger proteins for DNA binding and gene regulation in plants

0

US Patent 7361635 Simultaneous modulation of multiple genes

0

US Patent 7888121 Methods and compositions for targeted cleavage and recombination

0

...

Patent Primary Examiner

0

Patent abstract

Nucleases and methods of using these nucleases for expressing a transgene from a safe harbor locus in a secretory tissue, and clones and animals derived therefrom.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11859190 Methods and compositions for regulation of transgene expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.